Ecotropic Viral Integration Site 5 (EVI5) expression analysis in multiple sclerosis patients

Mehrdokht Mazdeh1,2, Mahnoosh Rahimi3, Mohammad Mahdi Eftekharian1

  • 1Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran.

Human Antibodies
|October 18, 2017
PubMed
Summary

This study found no significant difference in Ecotropic Viral Integration Site 5 (EVI5) gene expression in the blood of multiple sclerosis (MS) patients compared to healthy individuals. Further research is needed to understand EVI5's role in MS.

Related Concept Videos